Experience of ZHANG Boli in Staged Treating Very Early Onset Inflammatory Bowel Disease Based on the Theory of “Similar Diseases and Syndromes of Damp-Turbidity-Phlegm-Rheum”
QIN Guangning,LIU Yaoyuan,GAO Ning,et al.Experience of ZHANG Boli in Staged Treating Very Early Onset Inflammatory Bowel Disease Based on the Theory of “Similar Diseases and Syndromes of Damp-Turbidity-Phlegm-Rheum”[J].Journal of Traditional Chinese Medicine,2023,64(22):2282-2286.
QIN Guangning,LIU Yaoyuan,GAO Ning,et al.Experience of ZHANG Boli in Staged Treating Very Early Onset Inflammatory Bowel Disease Based on the Theory of “Similar Diseases and Syndromes of Damp-Turbidity-Phlegm-Rheum”[J].Journal of Traditional Chinese Medicine,2023,64(22):2282-2286.DOI: 10.13288/j.11-2166/r.2023.22.003.
This article summarizes the experience of Professor ZHANG Boli in the staged treatment of very early onset inflammatory bowel disease (VEO-IBD). Grounded in the theory of “similar diseases and syndromes of damp-turbidity-phlegm-rheum”, it is believed that dampness and turbidity are crucial pathogenic factors in VEO-IBD. During the acute phase, the core pathogenesis centers on the accumulation of turbid toxins in the intestines. The treatment focuses on dispelling dampness and clearing turbidity to eliminate turbid toxins, while also regulating the flow of
qi
and nourishing the spleen and kidney. During the remission phase, the core pathogenesis involves spleen and kidney deficiency, which is treated by invigorating the spleen and warming the kidney to strengthen the body resistance. Additionally, promoting blood circulation and eliminating stasis is integrated throughout the treatment process. Medications are chosen to be mild and gentle, emphasizing balance and harmony, and attention is given to the methods of administration and psychological well-being, ensuring comprehensive care for both body and mind.
关键词
Keywords
references
USAMI M , TAKEUCHI I , KYODO R , et al . Clinical features of very early-onset inflammatory bowel disease in Japan: a retrospective single-center study [J]. Intest Res , 2022 , 20 ( 4 ): 475 - 481 .
GLOCKER EO , KOTLARZ D , BOZTUG K , et al . Inflamma-tory bowel disease and mutations affecting the interleukin-10 receptor [J]. N Engl J Med , 2009 , 361 ( 21 ): 2033 - 2045 .